How do you measure a year? Time? Worldly events? Personal growth? There are many things that you could measure the time of the year against. Here...
The article 2022 Review: 3 Trials Pushing Boundaries of Psychedelic Medicine was originally published on Microdose. In my most recent article, The Top...
This list of our favorite reads from the past year shows how dramatically the psychedelics field is growing, from policy changes and therapy programs to...
The article 2022 End of Year Review: atai Life Sciences was originally published on Microdose. The end of the year is a convenient time to look...
This week Auntie helps research a form of iboga that you can allegedly microdose, answers whether drinking orange juice helps relieve challenging mushroom...
Also a peek at their plans for the year ahead. The post How 5 Psychedelics Companies Fared in 2022 appeared first on Green Market Report.
The article Top 5 Psychedelic Milestones of 2022 was originally published on Microdose. As we turn the final pages of 2022, it’s important to take a...
As psychedelic-assisted therapies near FDA approval, questions remain about cost, who's paying, and how much it saves patients and insurers in the long...
The article Gilgamesh Pharmaceuticals Raises $39 Million in Series B Financing was originally published on Microdose. Gilgamesh Pharmaceuticals has announced...
The article PharmaTher Receives FDA Orphan Drug Designation for Ketamine was originally published on Microdose. For more on Pharmather, check out PharmaTher...